HighVista Strategies’s IDEAYA Biosciences IDYA Stock Holding History

HighVista Strategies’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-47,728	Closed	-$1.23M	–	156
2024 Q4	$1.23M	Buy	+47,728	New	+$1.35M	0.46%	100
2024 Q3	–	Sell	-40,856	Closed	-$1.43M	–	156
2024 Q2	$1.43M	Sell	40,856 -58,436	-59%	-$2.31M	0.52%	72
2024 Q1	$4.36M	Sell	99,292 -27,553	-22%	-$1.18M	1.55%	11
2023 Q4	$4.51M	Hold	126,845	–	–	1.64%	6
2023 Q3	$3.42M	Buy	+126,845	New	+$3.22M	1.58%	13
2022 Q3	–	Sell	-130,380	Closed	-$1.8M	–	118
2022 Q2	$1.8M	Buy	130,380 +80,853	+163%	+$899K	1.09%	30
2022 Q1	$554K	Buy	49,527 +8,908	+22%	+$131K	0.35%	70
2021 Q4	$960K	Buy	+40,619	New	+$944K	0.76%	50

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HighVista Strategies's IDYA Position: Q1 2025 in Review

HighVista Strategies sold out of IDEAYA Biosciences (IDYA) in Q1 2025, closing a stake of 47,728 shares — an estimated $1.23M sold.

HighVista Strategies first reported a position in IDYA in Q4 2021 and held it in 8 quarters. The position peaked at $4.51M in Q4 2023. 207 funds tracked by Wall St. Rank hold IDYA as of Q1 2025.

HighVista Strategies reported no remaining IDEAYA Biosciences position as of Q1 2025 after selling out during the quarter.
HighVista Strategies sold 47,728 IDEAYA Biosciences shares in Q1 2025, an estimated $1.23M.
HighVista Strategies first reported a position in IDEAYA Biosciences in Q4 2021 and held it in 8 quarters.
HighVista Strategies's IDEAYA Biosciences position peaked at $4.51M in Q4 2023.
207 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2025.

Based on HighVista Strategies's 13F filing for Q1 2025, filed 15 May 2025.